Yingjie Li
Papers
1
Total Citations
11
H-Index
1
About
Yingjie Li is a urological surgeon and clinical researcher whose work sits at the forefront of robotic surgery and minimally invasive urology. His research focuses on the comparative evaluation of surgical robotic systems, with particular emphasis on advancing the adoption of domestically developed platforms as viable alternatives to established international systems. His most notable contribution to date is a landmark multicenter prospective randomized controlled trial comparing the KangDuo Surgical Robot-01 system against the widely used da Vinci system for robot-assisted radical nephroureterectomy — a technically demanding procedure for upper urinary tract malignancies. This rigorous study, which has already garnered 11 citations since its 2024 publication, represents a significant step toward validating next-generation surgical robotics and broadening access to advanced operative technologies. By generating high-quality evidence through randomized controlled methodology, Li's work directly informs surgical decision-making and health policy surrounding robotic platform selection. His contributions are especially meaningful for institutions in regions where cost and availability have historically limited access to robotic surgery, positioning him as an important voice in the global evolution of urological oncology and surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1